These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8222382)

  • 1. Antiplatelet therapy in the treatment of cerebrovascular disease.
    Couch JR
    Clin Cardiol; 1993 Oct; 16(10):703-10. PubMed ID: 8222382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy in the prevention of ischaemic stroke.
    Verry M; Panak E; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet therapy in the prevention of stroke.
    Easton JD
    Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy in the treatment of atherothrombotic disease: considering the evidence.
    Aronow WS
    Geriatrics; 2007 Apr; 62(4):12-24. PubMed ID: 17408314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.
    Bellavance A
    Stroke; 1993 Oct; 24(10):1452-7. PubMed ID: 8378945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
    Gouya G; Arrich J; Wolzt M; Huber K; Verheugt FW; Gurbel PA; Pirker-Kees A; Siller-Matula JM
    Stroke; 2014 Feb; 45(2):492-503. PubMed ID: 24368560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease.
    Harbison JW
    Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S17-20. PubMed ID: 9784798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel for cerebrovascular prevention.
    Paciaroni M; Bogousslavsky J
    Cerebrovasc Dis; 1999; 9(5):253-60. PubMed ID: 10473907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antiplatelet medication for prevention of myocardial infarction and stroke.
    Rakel RE
    Heart Dis Stroke; 1992; 1(1):2-3. PubMed ID: 1344081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke prevention in women: role of aspirin versus ticlopidine.
    Hershey LA
    Am J Med; 1991 Sep; 91(3):288-92. PubMed ID: 1832517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
    Hankey GJ; Sudlow CL; Dunbabin DW
    Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What have we learned from recent antiplatelet trials?
    Easton JD
    Neurology; 1998 Sep; 51(3 Suppl 3):S36-8. PubMed ID: 9744831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial.
    Gorelick PB; Richardson D; Kelly M; Ruland S; Hung E; Harris Y; Kittner S; Leurgans S;
    JAMA; 2003 Jun; 289(22):2947-57. PubMed ID: 12799402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticlopidine: a new antiplatelet agent for cerebrovascular disease.
    Robert S; Miller AJ; Fagan SC
    Pharmacotherapy; 1991; 11(4):317-22; discussion 322-5. PubMed ID: 1923914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.